April 3, 2018 / 2:51 PM / a year ago

Pfizer in talks with P&G for consumer health unit sale - CNBC

A logo of Pfizer is displayed on a monitor outside of the New York Stock Exchange shortly after the opening bell in New York, U.S., December 5, 2017. REUTERS/Lucas Jackson

(Reuters) - Pfizer Inc (PFE.N) is in talks with Procter & Gamble Co (PG.N) for a sale of the largest U.S. drugmaker’s consumer health business, CNBC reported on Tuesday, citing sources.

The companies were far apart on a price for the business and Pfizer is considering other options, including a joint venture with other drugmakers, the report said.

Pfizer said it is evaluating potential strategic options for the unit and expects to make a decision in 2018.

GlaxoSmithKline (GSK.L), Reckitt Benckiser (RB.L) and Johnson & Johnson (JNJ.N) have all exited from the bidding process, endangering an auction Pfizer hoped would bring in as much as $20 billion

P&G said it declined to comment.

Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below